Literature DB >> 33628118

Cytomegalovirus Infection and Its Relationship with Leukocyte Telomere Length: A Cross-Sectional Study.

Zhu Lin1, Hongmei Gao1, Bing Wang1, Yongqiang Wang1.   

Abstract

BACKGROUND: Telomeres undergo shortening with each cell division, which could be accelerated by infection. The association between virus infection and telomere length is poorly understood. In the present study, we investigated the putative associations between leukocyte telomere length (TL), cytomegalovirus (CMV) infection, and C-reactive protein (CRP) in a national representative sample of noninstitutionalized population.
METHODS: We analyzed data that was collected in a cross-sectional setting, where 3,987 participants were enrolled with available data on telomere length. The association between telomere length with previous CMV infection and CRP was analyzed using multivariable linear regression models. We further tested if obesity, measured by body mass index (BMI), and smoking could modify this relationship.
RESULTS: In total, around 46% percent of the study population were men and 54% were women. Average ages were 35.1 years for men and 35.0 years for women. One unit increase of CMV antibody IgG titer was associated with -0.07 (95% confidence interval: -0.12, -0.01) unit decrease of leukocyte TL when sex was adjusted for. After additionally adjusting for BMI and smoking status, the magnitude of the association was only slightly decreased to -0.06 (95% confidence interval: -0.11, -0.01). The effect sizes were comparable after additionally adjusting for CRP. These analyses imply that previous CMV infection affects leukocyte TL through pathways other than CRP.
CONCLUSIONS: Previous CMV infection was associated with shorter leukocyte TL. This association was independent of CRP.
Copyright © 2021 Zhu Lin et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33628118      PMCID: PMC7899777          DOI: 10.1155/2021/6675353

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  28 in total

Review 1.  Effect of obesity on telomere length: Systematic review and meta-analysis.

Authors:  Eduardo Mundstock; Edgar E Sarria; Helen Zatti; Fernanda Mattos Louzada; Lucas Kich Grun; Marcus Herbert Jones; Fátima T C R Guma; João Mazzola In Memoriam; Matias Epifanio; Renato T Stein; Florencia M Barbé-Tuana; Rita Mattiello
Journal:  Obesity (Silver Spring)       Date:  2015-09-26       Impact factor: 5.002

2.  A short leucocyte telomere length is associated with development of insulin resistance.

Authors:  Simon Verhulst; Christine Dalgård; Carlos Labat; Jeremy D Kark; Masayuki Kimura; Kaare Christensen; Simon Toupance; Abraham Aviv; Kirsten O Kyvik; Athanase Benetos
Journal:  Diabetologia       Date:  2016-03-28       Impact factor: 10.122

3.  Association of telomere length with general cognitive trajectories: a meta-analysis of four prospective cohort studies.

Authors:  Yiqiang Zhan; Mark S Clements; Rosebud O Roberts; Maria Vassilaki; Brooke R Druliner; Lisa A Boardman; Ronald C Petersen; Chandra A Reynolds; Nancy L Pedersen; Sara Hägg
Journal:  Neurobiol Aging       Date:  2018-06-02       Impact factor: 4.673

4.  Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome.

Authors:  Daiana Cristina Chielli Pedroso; Cristiana Libardi Miranda-Furtado; Gislaine Satyko Kogure; Juliana Meola; Maja Okuka; Celso Silva; Rodrigo T Calado; Rui Alberto Ferriani; David L Keefe; Rosana Maria dos Reis
Journal:  Fertil Steril       Date:  2014-11-20       Impact factor: 7.329

5.  C-reactive protein mediates the effect of apolipoprotein E on cytomegalovirus infection.

Authors:  Allison E Aiello; Hoang-Oanh T Nguyen; Mary N Haan
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

6.  The immune response to human CMV.

Authors:  Corinna La Rosa; Don J Diamond
Journal:  Future Virol       Date:  2012-03-01       Impact factor: 1.831

7.  Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

Authors:  Philip C Haycock; Stephen Burgess; Aayah Nounu; Jie Zheng; George N Okoli; Jack Bowden; Kaitlin Hazel Wade; Nicholas J Timpson; David M Evans; Peter Willeit; Abraham Aviv; Tom R Gaunt; Gibran Hemani; Massimo Mangino; Hayley Patricia Ellis; Kathreena M Kurian; Karen A Pooley; Rosalind A Eeles; Jeffrey E Lee; Shenying Fang; Wei V Chen; Matthew H Law; Lisa M Bowdler; Mark M Iles; Qiong Yang; Bradford B Worrall; Hugh Stephen Markus; Rayjean J Hung; Chris I Amos; Amanda B Spurdle; Deborah J Thompson; Tracy A O'Mara; Brian Wolpin; Laufey Amundadottir; Rachael Stolzenberg-Solomon; Antonia Trichopoulou; N Charlotte Onland-Moret; Eiliv Lund; Eric J Duell; Federico Canzian; Gianluca Severi; Kim Overvad; Marc J Gunter; Rosario Tumino; Ulrika Svenson; Andre van Rij; Annette F Baas; Matthew J Bown; Nilesh J Samani; Femke N G van t'Hof; Gerard Tromp; Gregory T Jones; Helena Kuivaniemi; James R Elmore; Mattias Johansson; James Mckay; Ghislaine Scelo; Robert Carreras-Torres; Valerie Gaborieau; Paul Brennan; Paige M Bracci; Rachel E Neale; Sara H Olson; Steven Gallinger; Donghui Li; Gloria M Petersen; Harvey A Risch; Alison P Klein; Jiali Han; Christian C Abnet; Neal D Freedman; Philip R Taylor; John M Maris; Katja K Aben; Lambertus A Kiemeney; Sita H Vermeulen; John K Wiencke; Kyle M Walsh; Margaret Wrensch; Terri Rice; Clare Turnbull; Kevin Litchfield; Lavinia Paternoster; Marie Standl; Gonçalo R Abecasis; John Paul SanGiovanni; Yong Li; Vladan Mijatovic; Yadav Sapkota; Siew-Kee Low; Krina T Zondervan; Grant W Montgomery; Dale R Nyholt; David A van Heel; Karen Hunt; Dan E Arking; Foram N Ashar; Nona Sotoodehnia; Daniel Woo; Jonathan Rosand; Mary E Comeau; W Mark Brown; Edwin K Silverman; John E Hokanson; Michael H Cho; Jennie Hui; Manuel A Ferreira; Philip J Thompson; Alanna C Morrison; Janine F Felix; Nicholas L Smith; Angela M Christiano; Lynn Petukhova; Regina C Betz; Xing Fan; Xuejun Zhang; Caihong Zhu; Carl D Langefeld; Susan D Thompson; Feijie Wang; Xu Lin; David A Schwartz; Tasha Fingerlin; Jerome I Rotter; Mary Frances Cotch; Richard A Jensen; Matthias Munz; Henrik Dommisch; Arne S Schaefer; Fang Han; Hanna M Ollila; Ryan P Hillary; Omar Albagha; Stuart H Ralston; Chenjie Zeng; Wei Zheng; Xiao-Ou Shu; Andre Reis; Steffen Uebe; Ulrike Hüffmeier; Yoshiya Kawamura; Takeshi Otowa; Tsukasa Sasaki; Martin Lloyd Hibberd; Sonia Davila; Gang Xie; Katherine Siminovitch; Jin-Xin Bei; Yi-Xin Zeng; Asta Försti; Bowang Chen; Stefano Landi; Andre Franke; Annegret Fischer; David Ellinghaus; Carlos Flores; Imre Noth; Shwu-Fan Ma; Jia Nee Foo; Jianjun Liu; Jong-Won Kim; David G Cox; Olivier Delattre; Olivier Mirabeau; Christine F Skibola; Clara S Tang; Merce Garcia-Barcelo; Kai-Ping Chang; Wen-Hui Su; Yu-Sun Chang; Nicholas G Martin; Scott Gordon; Tracey D Wade; Chaeyoung Lee; Michiaki Kubo; Pei-Chieng Cha; Yusuke Nakamura; Daniel Levy; Masayuki Kimura; Shih-Jen Hwang; Steven Hunt; Tim Spector; Nicole Soranzo; Ani W Manichaikul; R Graham Barr; Bratati Kahali; Elizabeth Speliotes; Laura M Yerges-Armstrong; Ching-Yu Cheng; Jost B Jonas; Tien Yin Wong; Isabella Fogh; Kuang Lin; John F Powell; Kenneth Rice; Caroline L Relton; Richard M Martin; George Davey Smith
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

8.  Short leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study.

Authors:  Jinying Zhao; Yun Zhu; Jue Lin; Tet Matsuguchi; Elizabeth Blackburn; Ying Zhang; Shelley A Cole; Lyle G Best; Elisa T Lee; Barbara V Howard
Journal:  Diabetes       Date:  2013-08-15       Impact factor: 9.461

9.  Telomere Shortening, Inflammatory Cytokines, and Anti-Cytomegalovirus Antibody Follow Distinct Age-Associated Trajectories in Humans.

Authors:  Ana Lustig; Hans B Liu; E Jeffrey Metter; Yang An; Melissa A Swaby; Palchamy Elango; Luigi Ferrucci; Richard J Hodes; Nan-Ping Weng
Journal:  Front Immunol       Date:  2017-08-24       Impact factor: 7.561

10.  Telomeres and COVID-19.

Authors:  Abraham Aviv
Journal:  FASEB J       Date:  2020-05-19       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.